XENOVA LIMITED
Patent Owner
Stats
- 7 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Apr 28, 2009 most recent publication
Details
- 7 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 400 Total Citation Count
- Jun 21, 1983 Earliest Filing
- 31 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6218393 Anthranilic acid derivatives as multi drug resistance modulatorsJun 09, 99Apr 17, 01[A61K, C07D]
6054127 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameJun 27, 97Apr 25, 00[A61K, C07D]
5876727 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameSep 30, 96Mar 02, 99[A61K, C07D]
5840307 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparationJun 01, 95Nov 24, 98[A61K, C07P]
5773003 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameJun 01, 95Jun 30, 98[A61K]
5760184 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameNov 28, 95Jun 02, 98[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7524861 Process for the preparation of a hydrate of an anthranilic acid derivativeExpiredMay 13, 03Apr 28, 09[A61K, C07D]
2006/0286,094 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameAbandonedJun 19, 06Dec 21, 06[A61K, C07D, C07K]
2006/0286,095 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameAbandonedJun 19, 06Dec 21, 06[A61K, C07D, C07K]
2006/0286,096 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameAbandonedJun 19, 06Dec 21, 06[A61K, C07D, C07K]
2006/0286,097 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameAbandonedJun 19, 06Dec 21, 06[A61K, C07D, C07K]
2006/0286,098 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameAbandonedJun 19, 06Dec 21, 06[A61K, C07D, C07K]
2006/0286,099 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameAbandonedJun 19, 06Dec 21, 06[A61K, C07D, C07K]
2006/0280,735 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameAbandonedJun 19, 06Dec 14, 06[A61K, C07K]
2006/0280,736 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameAbandonedJun 19, 06Dec 14, 06[A61K, C07D, C07K]
2006/0239,997 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameAbandonedJun 19, 06Oct 26, 06[A61K, C12P, G01N, C07K]
2006/0058,220 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameAbandonedFeb 23, 05Mar 16, 06[A61K]
2005/0124,061 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameAbandonedAug 22, 03Jun 09, 05[C12P, C12N, C07K]
2003/0139,409 Benzo[A] [phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and IIAbandonedSep 18, 02Jul 24, 03[A61K, C07D]
2003/0069,400 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameAbandonedApr 01, 02Apr 10, 03[G01N, C07K]
2002/0032,316 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameAbandonedJun 14, 01Mar 14, 02[C07K]
6114332 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumor agentsExpiredJun 18, 99Sep 05, 00[A01N, C07D]
6111109 Process for the preparation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamideExpiredJun 18, 99Aug 29, 00[C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.